Cytogen taps Schnittker as VP and CFO

TriMed Staff | | Health Imaging | Artificial Intelligence
Cytogen Corp. has tapped Christopher P. Schnittker as vice president and CFO. Before coming on board at Cytogen, Schnittker served as CFO at biopharmaceutical company  Genaera Corp. (formerly Magainin Pharmaceuticals Inc.) from June 2000 to August 2003. Prior to Genaera, Schnittker served at technology firm GSI Commerce Inc. as director of finance from August 1999 to May 2000 and controller from December 1997 to August 1999.

TriMed Staff

Related Content

AI reduces CT lung cancer screening workload by nearly 80%
How AI and CCTA help heart teams plan ahead before PCI
5 steps for evaluating radiology AI applications
Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings
New algorithm models radiologists' eye movements to interpret chest X-rays
Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.